Compare Sterling Biotech with FDC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs FDC - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH FDC STERLING BIOTECH/
FDC
 
P/E (TTM) x -0.4 23.7 - View Chart
P/BV x 0.0 4.6 0.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   FDC
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
FDC
Mar-18
STERLING BIOTECH/
FDC
5-Yr Chart
Click to enlarge
High Rs11319 3.3%   
Low Rs3164 2.1%   
Sales per share (Unadj.) Rs26.861.6 43.5%  
Earnings per share (Unadj.) Rs-15.09.9 -150.3%  
Cash flow per share (Unadj.) Rs-5.512.0 -45.7%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.973.2 75.0%  
Shares outstanding (eoy) m267.87174.40 153.6%   
Bonus / Rights / Conversions -BB-  
Price / Sales ratio x0.33.9 6.6%   
Avg P/E ratio x-0.524.3 -1.9%  
P/CF ratio (eoy) x-1.320.2 -6.3%  
Price / Book Value ratio x0.13.3 3.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,86242,118 4.4%   
No. of employees `0001.45.5 24.5%   
Total wages/salary Rs m5472,167 25.2%   
Avg. sales/employee Rs Th5,303.31,943.7 272.8%   
Avg. wages/employee Rs Th403.8391.7 103.1%   
Avg. net profit/employee Rs Th-2,959.0313.7 -943.2%   
INCOME DATA
Net Sales Rs m7,18110,751 66.8%  
Other income Rs m43510 8.4%   
Total revenues Rs m7,22311,260 64.1%   
Gross profit Rs m9472,267 41.8%  
Depreciation Rs m2,543351 723.7%   
Interest Rs m4,37714 31,265.0%   
Profit before tax Rs m-5,9312,411 -246.0%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924671 -286.7%   
Profit after tax Rs m-4,0071,735 -230.9%  
Gross profit margin %13.221.1 62.5%  
Effective tax rate %32.427.8 116.6%   
Net profit margin %-55.816.1 -345.7%  
BALANCE SHEET DATA
Current assets Rs m14,3357,213 198.8%   
Current liabilities Rs m49,8092,104 2,367.7%   
Net working cap to sales %-494.047.5 -1,039.6%  
Current ratio x0.33.4 8.4%  
Inventory Days Days40354 740.3%  
Debtors Days Days17128 615.5%  
Net fixed assets Rs m55,4326,865 807.5%   
Share capital Rs m268175 152.9%   
"Free" reserves Rs m13,93512,586 110.7%   
Net worth Rs m14,70112,761 115.2%   
Long term debt Rs m9,4786 157,964.2%   
Total assets Rs m73,98815,041 491.9%  
Interest coverage x-0.4173.2 -0.2%   
Debt to equity ratio x0.60 137,117.4%  
Sales to assets ratio x0.10.7 13.6%   
Return on assets %0.511.6 4.3%  
Return on equity %-27.313.6 -200.4%  
Return on capital %-6.419.0 -33.9%  
Exports to sales %25.912.3 209.8%   
Imports to sales %0.20-   
Exports (fob) Rs m1,8601,327 140.2%   
Imports (cif) Rs m12NA-   
Fx inflow Rs m1,8601,889 98.5%   
Fx outflow Rs m250-   
Net fx Rs m1,8351,889 97.1%   
CASH FLOW
From Operations Rs m1,7191,498 114.7%  
From Investments Rs m-3,148201 -1,565.5%  
From Financial Activity Rs m1,426-1,694 -84.2%  
Net Cashflow Rs m-310 -33.0%  

Share Holding

Indian Promoters % 33.9 68.9 49.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.7 -  
FIIs % 9.9 7.5 132.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 19.0 206.8%  
Shareholders   21,482 23,730 90.5%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   DR. REDDYS LAB  PIRAMAL ENTERPRISES  NATCO PHARMA  NEULAND LABS  PFIZER  

Compare STERLING BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

FDC LTD. Announces Quarterly Results (3QFY20); Net Profit Up 67.7% (Quarterly Result Update)

Feb 10, 2020 | Updated on Feb 10, 2020

For the quarter ended December 2019, FDC LTD. has posted a net profit of Rs 733 m (up 67.7% YoY). Sales on the other hand came in at Rs 3 bn (up 26.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (3QFY20); Net Profit Up 67.7% (Quarterly Result Update)

Feb 10, 2020 | Updated on Feb 10, 2020

For the quarter ended December 2019, FDC LTD. has posted a net profit of Rs 733 m (up 67.7% YoY). Sales on the other hand came in at Rs 3 bn (up 26.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS